Table 3. ELISA end-point titers of H7 Monoclonal Antibodies (mAbs).
| Virus | ELISA End-point Titers (μg/ml)a | |||
|---|---|---|---|---|
| 5A6* | 4A2* | 2C4* | H9-A22** | |
| A/Shanghai/02/2013 | 0.02 | 0.04 | 0.02 | >4 |
| A/Shanghai/02/2013 A143T | 0.2 | 0.4 | 0.2 | >4 |
| A/Shanghai/02/2013 S183D | 0.02 | 0.04 | 0.02 | >4 |
| A/Shanghai/02/2013 V195G | 0.01 | 0.02 | 0.01 | >4 |
| A/Shanghai/02/2013 A198T | 0.02 | 0.04 | 0.02 | >4 |
| A/Netherlands/219/2003 | 0.4 | 0.4 | 0.4 | >4 |
| A/Netherlands/219/2003 T143A | 0.02 | 0.04 | 0.02 | >4 |
| A/Netherlands/219/2003 D183S | 0.4 | 0.4 | 0.4 | >4 |
| A/Netherlands/219/2003 G195V | 0.4 | 0.4 | 0.4 | >4 |
| A/Netherlands/219/2003 T198V | 0.4 | 0.4 | 0.4 | >4 |
| A/Puerto Rico/8/1934 | >4 | >4 | >4 | 0.001 |
a The end-point titer was defined as the lowest antibody concentration that gave an absorbance value greater than 0.05 at 450 nm.
* mAbs 5A6, 4A2, and 2C4 to site A were raised against HA of A/Shanghai/02/2013.
** mAb were raised against A/Puerto Rico/8/1934.